ZA951220B - Substituted cyclohexanol esters their use for treating diseases and pharmaceutical preparations - Google Patents

Substituted cyclohexanol esters their use for treating diseases and pharmaceutical preparations

Info

Publication number
ZA951220B
ZA951220B ZA951220A ZA951220A ZA951220B ZA 951220 B ZA951220 B ZA 951220B ZA 951220 A ZA951220 A ZA 951220A ZA 951220 A ZA951220 A ZA 951220A ZA 951220 B ZA951220 B ZA 951220B
Authority
ZA
South Africa
Prior art keywords
opt
pharmaceutical preparations
treating diseases
substd
alkyl
Prior art date
Application number
ZA951220A
Other languages
English (en)
Inventor
Horst Hemmerle
Gerrit Schubert
Peter Below
Andreas Herling
Hans-Joerg Burger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA951220B publication Critical patent/ZA951220B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA951220A 1994-02-16 1995-02-15 Substituted cyclohexanol esters their use for treating diseases and pharmaceutical preparations ZA951220B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4404848A DE4404848A1 (de) 1994-02-16 1994-02-16 Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
ZA951220B true ZA951220B (en) 1995-10-11

Family

ID=6510346

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951220A ZA951220B (en) 1994-02-16 1995-02-15 Substituted cyclohexanol esters their use for treating diseases and pharmaceutical preparations

Country Status (21)

Country Link
US (3) US5567725A (cs)
EP (1) EP0672660B1 (cs)
JP (1) JPH07258220A (cs)
KR (1) KR100360128B1 (cs)
CN (1) CN1051298C (cs)
AT (1) ATE309222T1 (cs)
AU (1) AU679305B2 (cs)
CA (1) CA2142556A1 (cs)
CZ (1) CZ290065B6 (cs)
DE (2) DE4404848A1 (cs)
ES (1) ES2250966T3 (cs)
FI (1) FI950649A7 (cs)
HU (1) HUT73631A (cs)
IL (1) IL112655A (cs)
NO (1) NO305754B1 (cs)
NZ (1) NZ270490A (cs)
PL (1) PL178970B1 (cs)
RU (1) RU2135465C1 (cs)
SG (1) SG46690A1 (cs)
TW (1) TW295578B (cs)
ZA (1) ZA951220B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523879A (en) * 2000-08-16 2004-09-24 F Novel aminocyclohexane derivatives, their manufacture and their use as 2,3-oxidosqualene-lanosterol cyclase inhibiting medicaments
JP2004535411A (ja) * 2001-05-25 2004-11-25 ブリストルーマイヤーズ スクイブ カンパニー マトリックスメタロプロテナーゼ及び／またはＴＮＦ−α転換酵素（ＴＡＣＥ）の阻害剤としてのヒダントイン及び関連複素環化合物
WO2013134562A1 (en) 2012-03-09 2013-09-12 Inception 2, Inc. Triazolone compounds and uses thereof
DK2935228T3 (en) 2012-12-20 2017-10-30 Inception 2 Inc TRIAZOLONE COMPOUNDS AND APPLICATIONS THEREOF
US9776976B2 (en) 2013-09-06 2017-10-03 Inception 2, Inc. Triazolone compounds and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3440117A1 (de) * 1984-11-02 1986-05-15 Bayer Ag, 5090 Leverkusen Substituierte azolylcyclopropyl-azolylmethyl-carbinol-derivate
GB8512163D0 (en) * 1985-05-14 1985-06-19 Fujisawa Pharmaceutical Co Oxothiazolidine compound
IL93051A0 (en) * 1989-01-17 1990-11-05 Hoffmann La Roche ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides,their preparation and pharmaceutical compositions containing them
US5015653A (en) * 1989-07-10 1991-05-14 Hoffmann-La Roche Inc. [(5-oxo)-2-pyrrolidinyl)methyl]cyclohexaneacetamides, compositions and use
DE4202184A1 (de) * 1992-01-28 1993-07-29 Hoechst Ag Substituierte salicylaldehyde zur behandlung von krankheiten
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
TW255880B (cs) * 1992-09-09 1995-09-01 Hoechst Ag

Also Published As

Publication number Publication date
RU95101840A (ru) 1996-12-10
CA2142556A1 (en) 1995-08-17
HUT73631A (en) 1996-08-28
NO305754B1 (no) 1999-07-19
IL112655A (en) 2003-05-29
EP0672660A3 (de) 1997-05-28
KR100360128B1 (ko) 2003-04-26
PL178970B1 (pl) 2000-07-31
ATE309222T1 (de) 2005-11-15
FI950649L (fi) 1995-08-17
EP0672660B1 (de) 2005-11-09
CZ290065B6 (cs) 2002-05-15
DE4404848A1 (de) 1995-08-17
NO950564L (no) 1995-08-17
AU679305B2 (en) 1997-06-26
DE59511025D1 (de) 2005-12-15
CN1051298C (zh) 2000-04-12
AU1225595A (en) 1995-08-24
FI950649A7 (fi) 1995-08-17
FI950649A0 (fi) 1995-02-14
EP0672660A2 (de) 1995-09-20
NO950564D0 (no) 1995-02-15
RU2135465C1 (ru) 1999-08-27
PL307284A1 (en) 1995-08-21
ES2250966T3 (es) 2006-04-16
US5629311A (en) 1997-05-13
JPH07258220A (ja) 1995-10-09
HU9500456D0 (en) 1995-03-28
CZ37995A3 (en) 1995-09-13
KR950032136A (ko) 1995-12-20
CN1126198A (zh) 1996-07-10
IL112655A0 (en) 1995-05-26
US5567725A (en) 1996-10-22
SG46690A1 (en) 1998-02-20
US5719170A (en) 1998-02-17
TW295578B (cs) 1997-01-11
NZ270490A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
AU692090B2 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
EP1020470A3 (en) Galanthamine derivatives, a process for their preparation and their use as medicaments
GB1467138A (en) Acetylene derivatives of amino acids
IL112655A0 (en) Substituted cyclohexanol esters, their use for treating diseases and pharmaceutical preparations
MX9804106A (es) Sales de derivados de quinolina como antagonistas de nk3.
EP0299493A3 (en) N-û(2-oxopyrrolidin-1-yl)-acetyl¨piperazine derivatives and drug for senile dementia
GB9318691D0 (en) Therapeutic agents
TW252979B (cs)
AR017812A1 (es) Una solucion que comprende antibioticos de quinolona; y un metodo para preparar un medicamento para inyeccion contra una infeccion bacteriana
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
YU140491A (sh) 6-supstituisani-tetrahidrobenz(c,d) indoli
HUT76480A (en) Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
MX9603343A (es) Antagonistas del receptor endotelial, procedimiento para preparar dichos compuestos y preparaciones farmaceuticas que los contienen.
ES8404343A1 (es) Un procedimiento para la prepracion de nuevos derivados de 1,4-diaminociclitol.
HU900140D0 (en) Process for preparation of 1,8 benzonaphtridine-derivatives
EP0400916A3 (en) 4,5,6,11-Tetrahydrobenzo [6,7]-cycloocta[1,2-b]thiophen-6,11-imines and 6,11-dihydrobenzo[6,7]-cycloocta[1,2-b]thiophen-6,11 imines
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
DE69312322D1 (de) Cephem verbindungen mit antimicrobizide eigenschaften
ES8305307A1 (es) Un procedimiento para la preparacion de un aciltripeptido.
MX9603797A (es) Agentes terapeuticos para su uso en la terapia del cancer.
JO1660B1 (en) Benzimidazole compounds are a therapeutically effective substitute for chlorine and processes for preparing and using them
IT1241928B (it) Composizione oftalmica per l'uso nel mantenimento della midriasi oculare
RU94038051A (ru) Гетероциклические производные, способ их получения, фармацевтическая композиция и способ лечения